Full-Time

Field Access Manager

Plasma-Derived Therapies

Posted on 4/13/2025

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$145.6k - $200.2k/yr

+ Short-term Incentives + Long-term Incentives

Senior

Minnesota, USA + 2 more

More locations: Wisconsin, USA | Illinois, USA

Must live in the North Central territory (MN, IL, WI, IA, SD, or ND) and travel up to 75%.

Category
Customer Success
Strategic Account Management
Sales & Account Management
Required Skills
Sales
Requirements
  • Bachelor’s Degree.
  • 5+ years of field-based experience in account management, sales or medical affairs.
  • Strong knowledge of the reimbursement landscape and the practice management environment.
  • Demonstrated ability to develop and execute account-based strategies to drive access outcomes.
  • Excellent written and verbal communication skills.
  • Expertise in account management, relationship development, and issue resolution.
  • Outstanding interpersonal skills and flexibility to meet evolving customer and organizational needs.
Responsibilities
  • Serve as a key resource to navigate reimbursement and access challenges for patients and providers, ensuring timely and effective access to Takeda’s therapies.
  • Deliver tailored, field-based education on reimbursement processes to key accounts, including provider group practices, hospitals, academic institutions, specialty pharmacies, and other healthcare stakeholders.
  • Build and maintain collaborative relationships with healthcare organizations, identifying and resolving reimbursement and access issues to ensure seamless therapy initiation and continuation.
  • Provide education and support to internal teams, equipping colleagues with the knowledge and tools to address complex reimbursement and access scenarios effectively.
  • Stay informed on healthcare policies, reimbursement trends, and regulatory requirements to proactively address challenges and opportunities in the marketplace.
Desired Qualifications
  • Minimum of 5 years of relevant experience in reimbursement roles within the pharmaceutical, biotech, or rare disease industry.
  • MBA or advanced degree.
  • Experience in healthcare policy, reimbursement, market access, or related fields.
  • Familiarity with buy-and-bill and pharmacy models.
  • Experience with specialty or high-cost therapies in chronic or acute care settings.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized in all operations.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene is worth up to $770 million.
  • The company is expanding its market presence in emerging Asian economies.
  • Takeda's focus on personalized medicine aligns with industry trends.

What critics are saying

  • Antitrust litigation over Amitiza could harm Takeda's reputation and finances.
  • A data breach incident poses significant cybersecurity and legal risks.
  • The telehealth market's rapid changes may affect Takeda's investment in American Well.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations.
  • Takeda has a robust pipeline with 11 NMEs and aims for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

ETF Daily News
May 11th, 2025
Tudor Investment Corp ET AL Decreases Stock Holdings in American Well Co. (NYSE:AMWL)

Takeda Pharmaceutical Co. Ltd. acquired a new stake in American Well in the fourth quarter worth about $564,000.

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

INACTIVE